Home LiteratureArticle Details
PMID: 10550488 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli.

Psychopharmacology ·Vol. 146 ·No. 4 ·1999-10-00 ·Pages 373-90

Jentsch JD, Taylor JR

Abstract

Drug abuse and dependence define behavioral states involving increased allocation of behavior towards drug seeking and taking at the expense of more appropriate behavioral patterns. As such, addiction can be viewed as increased control of behavior by the desired drug (due to its unconditioned, rewarding properties). It is also clear that drug-associated (conditioned) stimuli acquire heightened abilities to control behaviors. These phenomena have been linked with dopamine function within the ventral striatum and amygdala and have been described specifically in terms of motivational and incentive learning processes. New data are emerging that suggest that regions of the frontal cortex involved in inhibitory response control are directly affected by long-term exposure to drugs of abuse. The result of chronic drug use may be frontal cortical cognitive dysfunction, resulting in an inability to inhibit inappropriate unconditioned or conditioned responses elicited by drugs, by related stimuli or by internal drive states. Drug-seeking behavior may thus be due to two related phenomena: (1) augmented incentive motivational qualities of the drug and associated stimuli (due to limbic/amygdalar dysfunction) and (2) impaired inhibitory control (due to frontal cortical dysfunction). In this review, we consider the neuro-anatomical and neurochemical substrates subserving inhibitory control and motivational processes in the rodent and primate brain and their putative impact on drug seeking. The evidence for cognitive impulsivity in drug abuse associated with dysfunction of the frontostriatal system will be discussed, and an integrative hypothesis for compulsive reward-seeking in drug abuse will be presented.

MeSH Terms
Animals Basal Ganglia/drug effects Behavior, Addictive/physiopathology,psychology Conditioning, Psychological Dopamine/metabolism Frontal Lobe/drug effects Humans Illicit Drugs/adverse effects Impulsive Behavior/etiology Models, Psychological Reward Substance-Related Disorders/etiology,physiopathology
Chemicals
Illicit Drugs Dopamine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Jentsch J D
Section of Neurobiology, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208001, New Haven, CT 06520-8001, USA. david.jentsch@yale.edu
Taylor J R
Article Info
Journal
Psychopharmacology
Abbr.
Psychopharmacology (Berl)
ISSN
0033-3158
Published
1999-10-00
Pages
373-90
Language
English
Region
Germany
NLM ID
7608025
Subset
IM
Grants
NIDA NIH HHS · DA11026 · United States
NIDA NIH HHS · DA11717 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com